mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.04 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |